Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

71.36USD
22 May 2017
Change (% chg)

$0.57 (+0.81%)
Prev Close
$70.79
Open
$70.80
Day's High
$71.79
Day's Low
$70.35
Volume
209,486
Avg. Vol
451,280
52-wk High
$111.00
52-wk Low
$65.49

Latest Key Developments (Source: Significant Developments)

Perrigo files 2016 form 10-k with restated financial statements
Monday, 22 May 2017 06:25pm EDT 

May 22 (Reuters) - Perrigo Company Plc :Perrigo files 2016 form 10-k with restated financial statements; reports fourth quarter and calendar year 2016 financial results; announces 2017 annual meeting date.Q4 sales $1.3 billion versus I/B/E/S view $1.36 billion.Sees FY 2017 adjusted earnings per share $4.15 to $4.50 including items.Sees FY 2017 earnings per share $0.22 to $0.57.Q4 adjusted earnings per share $1.24 excluding items.Q4 loss per share $9.48.Sees FY 2017 sales $4.6 billion to $4.8 billion.Q4 earnings per share view $1.81 -- Thomson Reuters I/B/E/S.During Q4 of 2016, company identified indicators of goodwill impairment in specialty sciences reporting unit.Recorded an impairment of $200 million in impairment charges on consolidated statement of operations within specialty sciences segment during Q4.During Q4 of 2016, company also identified indicators of goodwill impairment in animal health reporting unit.Animal Health goodwill was impaired by $25 million, recorded in impairment charges on statement of operations in CHC Americas segment in quarter.During Q4 of 2016, company identified impairment indicators in its entocort product assets.Determined that entocort product assets were impaired by $342 million.Also identified impairment indicators in certain definite-lived intangible assets in CHC International reporting segment.  Full Article

Perrigo Company Plc files for non-timely 10-Q
Thursday, 11 May 2017 05:29pm EDT 

May 11 (Reuters) - Perrigo Company Plc ::Perrigo Company plc files for non-timely 10-Q - sec filing.  Full Article

Perrigo sets quarterly dividend
Wednesday, 3 May 2017 08:51am EDT 

May 3 (Reuters) - Perrigo Company Plc :Sets quarterly dividend of $0.16per share.  Full Article

Perrigo says search warrants were executed at company's corporate offices
Tuesday, 2 May 2017 08:59pm EDT 

May 2 (Reuters) - Perrigo Company Plc :Perrigo discloses investigation.Search warrants were executed at company's corporate offices associated with an ongoing investigation by U.S. Department of Justice Antitrust Division related to drug pricing.Co is cooperating with appropriate authorities.  Full Article

Perrigo Company Plc appoints RONALD L. WINOWIECKI as principal accounting officer
Tuesday, 25 Apr 2017 05:04pm EDT 

April 25 (Reuters) - Perrigo Company Plc :Perrigo Company Plc - effective April 19, company's board appointed Ronald L. Winowiecki as company's principal accounting officer.Perrigo Company Plc - Winowiecki was appointed acting chief financial officer of company.Perrigo Company - on April 19, co entered amendment no. 5 and waiver to revolving credit agreement, dated as of December 5, 2014 .Perrigo- Lenders waived any default or event of default which may arise from restatement of financial statements for FY ended on or about June 30, 2015.  Full Article

Perrigo Sees FY 2017 sales $4.6 billion to $4.8 billion
Tuesday, 25 Apr 2017 04:03pm EDT 

April 25 (Reuters) - Perrigo Company Plc -:Perrigo announces restatement of previously issued forms 10-k and 10-q financial statements; announces select preliminary unaudited first quarter 2017 financial results.Sees FY 2017 sales $4.6 billion to $4.8 billion.Q1 sales $1.2 billion versus i/b/e/s view $1.24 billion.Perrigo Company Plc - accounting changes are not expected to have a material impact on net cash flows.Perrigo Company Plc - has determined that it is necessary to restate certain previously issued financial statements.Perrigo Company Plc - tysabri historical royalty stream determined to be a financial asset.Perrigo - to file 2016 10-k, including restated fiscal 2014, fiscal 2015 and transition period 2015 audited financials "as soon as practical".Perrigo - does not expect changes to previously issued financial statements to have material impact on net cash flows.Perrigo Company Plc - entered into amendments to term loan agreement and revolving credit agreement to remain in compliance with agreements.Perrigo Company Plc - sees fy cash flow from operations of greater than $575 million.Perrigo Company Plc - preliminary unaudited q1 2017 consolidated net sales were approximately $1.2 billion.Perrigo-Elected to account for tysabri financial asset using fair value option, which requires co to adjust financial statements for relevant periods.  Full Article

Perrigo completes divestiture of tysabri royalty stream for up to $2.85 billion
Monday, 27 Mar 2017 04:01pm EDT 

Perrigo Company Plc :Perrigo completes divestiture of Tysabri® royalty stream for up to $2.85 billion.  Full Article

Perrigo announced first-to-market launch of OTC store brand equivalent to women's Rogaine foam
Wednesday, 8 Mar 2017 08:35am EST 

Perrigo Company Plc :Perrigo Company Plc- announced first-to-market launch of over--counter store brand equivalent to women's Rogaine foam.  Full Article

Perrigo says in process of identifying certain deferred tax assets, other related effects at Omega Pharma Invest N.V
Tuesday, 7 Mar 2017 04:03pm EST 

Perrigo Company Plc : Perrigo provides 2016 form 10-k update . Perrigo provides 2016 form 10-k update . Perrigo Company Plc - in process of identifying certain deferred tax assets and other related effects at Omega Pharma Invest N.V. .Perrigo Company Plc - is in a quiet period regarding financial matters until March 16, 2017, filing due date under extension.  Full Article

Perrigo announces FDA final approval for the generic version of Axiron topical solution
Wednesday, 1 Mar 2017 08:55am EST 

Perrigo Company Plc :Perrigo announces FDA final approval for the generic version of Axiron topical solution, 30 mg/1.5 ml.  Full Article

More From Around the Web

BRIEF-Perrigo files 2016 form 10-k with restated financial statements

* Perrigo files 2016 form 10-k with restated financial statements; reports fourth quarter and calendar year 2016 financial results; announces 2017 annual meeting date